Ligand Pharmaceuticals, Inc. (LGND)

231.55 -0.44 (-0.19%) USD  |  NASDAQ  |  May 06, 16:00
235.00 +3.45 (+1.49%) After-Hours: 20:00
More

Ligand Pharmaceuticals Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Amicus Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade